Skip to content

Study · In vitro (cells) · 1996

1 result

Expression and synthesis of insulin-like growth factor (IGF)-I, -II and their receptors in human glioma cell lines.

Zumkeller W, Biernoth R, Kocialkowski S, Martinerie C, Schofield P, Perbal B, Westphal M

International journal of oncology1 Nov 1996Cited by 6 (Europe PMC)

PMID21541605 (opens in a new tab)DOI10.3892/ijo.9.5.983 (opens in a new tab)PepBankPUB-21541605
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Efficacy outcome

    In human glioma cell lines, Des-(1-3)IGF-I inhibited cell proliferation.

    In plain wordsIn cells, Des-(1-3)IGF-I inhibited glioma cell growth.

    Peptide
    IGF-1 DES (des(1-3)IGF-I)
    Outcome
    DecreaseGlioma cell proliferation
    Study

    humann: not reported in source

    Human glioma cell lines
    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Des-(1-3)IGF-I showed an unexpected inhibitory activity on glioma cell proliferation.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 2

    21 Oct 2026, 13:52 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.